Back
Nuvation Bio, Inc. 10K Form
Buy
75
NUVB
Nuvation Bio, Inc.
Last Price:
$8.55
Seasonality Move:
-2.71%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-05-21 | 10K | NUVB/Nuvation Bio, Inc. Annual |
| 2021-05-17 | 10Q | NUVB/Nuvation Bio, Inc. Quarterly |
| 2021-03-11 | 10K | NUVB/Nuvation Bio, Inc. Annual |
| 2020-11-16 | 10Q | NUVB/Nuvation Bio, Inc. Quarterly |
| 2020-08-14 | 10Q | NUVB/Nuvation Bio, Inc. Quarterly |
Receive NUVB News And Ratings
See the #1 stock for the next 7 days that we like better than NUVB
NUVB Financial Statistics
Sales & Book Value
| Annual Sales: | $7.9M |
|---|---|
| Cash Flow: | $-60.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.95 |
| Price / Book: | 8.99 |
Profitability
| EPS (TTM): | -0.64020 |
|---|---|
| Net Income (TTM): | $-217.5M |
| Gross Margin: | $112K |
| Return on Equity: | -52.16% |
| Return on Assets: | -38.11% |
Nuvation Bio, Inc. Earnings Forecast
Key Nuvation Bio, Inc. Financial Ratios
-
The Gross Profit Margin over the past 5 years for NUVB is 1.42%.
-
The Selling, General & Administrative Expenses for NUVB have been equal to 879.37% of Gross Profit Margin.
-
The Research & Development expenses have been 1,258.97% of Revenue.
-
The Net Earning history of NUVB is -7,213.76% of Total Revenues.
-
Per Share Earnings over the last 5 years have been positive in 1 years.
Nuvation Bio, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | NUVB |
| Website: | nuvationbio.com |
Debt
| Debt-to-Equity Ratio: | 0.64 |
|---|---|
| Current Ratio: | 8.48 |
| Quick Ratio: | 8.18 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NUVB Technical Analysis vs Fundamental Analysis
Buy
75
Nuvation Bio, Inc. (NUVB)
is a Buy
Is Nuvation Bio, Inc. a Buy or a Sell?
-
Nuvation Bio, Inc. stock is rated a BuyThe current Nuvation Bio, Inc. [NUVB] share price is $8.55. The Score for NUVB is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.